Munafa Stock Market Course + Intraday & FNO calls 
AUROPHARMA NEWS why is Aurobindo Pharma Limited price falling or rising
AUROPHARMA NEWS reasons for why stock price of Aurobindo Pharma Limited is falling or rising
AUROPHARMA Aurobindo Pharma is falling or rising technical reasons
Technical analysis forecast of Aurobindo Pharma Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Aurobindo Pharma AUROPHARMA at this time. Stock is rising and might rise more.
It appears as if Aurobindo Pharma AUROPHARMA gave a large move recently.
Stock of Aurobindo Pharma (AUROPHARMA) is trading above an important moving average line, but it crossed this line recently, which means that it could show a small or a large fall soon enough depending on its trend.
My analysis of Aurobindo Pharma is bullish for shortterm, but trade for tomorrow is selective. Take a BUY trade only if Aurobindo Pharma stays above 1687.4, but if it comes below 1687.4, then a intra day sell could be more profitable.
If you take a sell trade below 1687.4, then use 1687.4 as stoploss and 1656.67 as target. However if you take a buy trade in Aurobindo Pharma, then use 1687.4 as stoploss and 1724.3 as target.
AUROPHARMA Aurobindo Pharma is falling or rising NEWS fundamental reasons
Company Announcement Aurobindo Pharma Limited has informed the Exchange about Completion of US FDA Inspection at Unit-II of Apitoria Pharma Private Limited, a wholly owned subsidiary of the Company. - NEWS as on 2026-09-16
JM Financial sees up to 28% upside in Dr Reddy’s and Aurobindo Pharma. Should you buy? JM Financial retained Buy ratings on Dr Reddy’s Laboratories and Aurobindo Pharma, seeing up to 28% upside over the next 12 months. The brokerage expects stronger earnings growth, business diversification and new product launches to support both drugmakers - NEWS as on 2026-09-16 indiatimes.com
Aurobindo Pharma receives USFDA approval for Beclomethasone Dipropionate HFA Inhalation Aerosol Aurobindo Pharma announced that it has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Beclomethasone Dipropionate HFA Inhalation Aerosol, 40 mcg and 80 mcg, a generic equivalent of QVAR Inhalation Aerosol 4 - NEWS as on 2026-09-15 business-standard.com
Company Announcement Aurobindo Pharma Limited has informed the Exchange about Schedule of meet - NEWS as on 2026-09-15
Company Announcement - NEWS as on 2026-09-11
More announcements and NEWS
AUROPHARMA Aurobindo Pharma Limited current price & indicator signals
Recent prices of AUROPHARMA Aurobindo Pharma Limited are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 17 Thu Sep 2026 | 1690.00 | 1634.00 to 1692.30 | 2.86% | 1.12 times |
| 16 Wed Sep 2026 | 1643.00 | 1623.00 to 1657.10 | -1.02% | 0.77 times |
| 15 Tue Sep 2026 | 1660.00 | 1642.10 to 1688.00 | -1.18% | 0.65 times |
| 11 Fri Sep 2026 | 1679.80 | 1655.50 to 1681.40 | 0.68% | 0.73 times |
| 10 Thu Sep 2026 | 1668.40 | 1655.00 to 1693.40 | -1.8% | 1.18 times |
| 09 Wed Sep 2026 | 1698.90 | 1672.00 to 1704.00 | 0.41% | 0.89 times |
| 08 Tue Sep 2026 | 1692.00 | 1655.00 to 1698.80 | 1.93% | 1.56 times |
| 07 Mon Sep 2026 | 1660.00 | 1646.00 to 1668.00 | 0.42% | 0.79 times |
| 04 Fri Sep 2026 | 1653.10 | 1622.60 to 1661.50 | 0.97% | 0.85 times |
| 03 Thu Sep 2026 | 1637.30 | 1626.60 to 1666.60 | -0.66% | 1.36 times |
| 02 Wed Sep 2026 | 1648.20 | 1639.60 to 1695.00 | -2.09% | 1.21 times |
| 01 Tue Sep 2026 | 1683.30 | 1671.10 to 1700.10 | -1.96% | 0.9 times |
Videos related to: AUROPHARMA NEWS why is Aurobindo Pharma Limited price falling or rising
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
Hindi Basics How To Trade In FnO Futures Options Stock Market
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance
